Randomized, Double-blind, Placebo-controlled, Dose-escalation Study for the Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Oral Doses of GLPG1972 in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 27 Jul 2017
At a glance
- Drugs GLPG 1972 (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions; First in man
- Sponsors Galapagos NV
- 27 Jul 2017 Results published in the Media Release.
- 28 Jul 2016 Status changed from recruiting to completed.
- 24 May 2016 Planned End Date changed from 1 Apr 2016 to 1 Jun 2016.